pills

Healthcare DECODED

Previous edition: 20 May 2024
Share article

Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now

PureHealth launches platform for mental health

Sakina introduces services such as neurodiversity centres, inpatient institutes, satellite clinics, and mental health hubs.

PureHealth has launched Sakina, a new platform dedicated to enhancing mental wellness in line with Abu Dhabi's mental health strategy in the UAE. 

Sakina aims to help individuals with positive mental health and provide access to holistic care. It introduces a broad range of services, including neurodiversity centres, inpatient institutes, specialised satellite clinics, and outpatient mental health hubs, as well as homecare options.  

By offering these services, PureHealth will support the customisation of specialised psychiatry services, catering to diverse populations through early intervention, initial screening, and complete rehabilitation. 

To assist at-risk groups such as the elderly, women, children, People of Determination, and those dealing with addiction and eating disorders, Sakina will further offer secondary and tertiary care services.  

Sakina's services will be enhanced further through the use of a digital companion, named ‘Pura’, which is an AI-based longevity application by PureHealth.  

Pura provides personalised care, support, monitoring, and a full spectrum of psychiatry services. 

In addition, Sakina’s network will further be supported by 34 satellite clinics, two neurodiversity centres, two mental health hubs, and nine integrated clinics.  

The platform will employ more than 500 clinical professionals, including physicians and Sakina-trained nurses, backed by 77 administrative staff. 

PureHealth said that it will follow a tiered care approach to ensure psychiatric assistance is accessible, focusing on children aged from 0 to 10 years, adolescents between ten and 18 years old, as well as adults, including seniors, across all mental health concerns.  

The company will utilise the network, expertise, and technologies of its subsidiary SEHA to deliver exceptional mental health services through the latter's clinics and mobile access. 

Sakina CEO Dr Zain Al Yafai said: “By harnessing SEHA's comprehensive network of clinics and hospitals and cutting-edge digital technologies, providing a spectrum of inpatient and outpatient services from home care and therapies to catering to those with additional needs, Sakina has adopted a model of mental healthcare delivery that is embedded in the communities and that substantively supports all individuals, including the most vulnerable, in their pursuit of care that can meet them wherever they are, at home, on the move, and right in their communities.” 

Latest news

Fracture Liaison Service launches in Mid and South Essex

The service aims to strengthen the bones of individuals over 50, reduce fracture risks, and alleviate hospital bed occupancy.

Burjeel opens new Day Surgery Center in Al Ain, Abu Dhabi

The centre will reduce long hospital stays by offering advanced surgical interventions to treat several medical conditions.

Maine Medical Center's new Malone Family Tower to open next month

The tower will add 96 private patient rooms, nine procedure rooms, ten operating rooms, and 40 pre- and post-procedure beds.

HCG to open two cancer care centres in Bengaluru, India next year

The facilities, planned to be located in Whitefield and North Bengaluru areas, will have a combined capacity of 125 beds.

L&T to build new medical campus for Institute of Neurosciences Kolkata, India

The company has categorised the new order as “significant”, which is valued in the range of $119.9m to $299.7m.

athenahealth introduces new specialty care offerings

The two new offerings incorporate the comprehensive features of athenahealth's EHR and practice management solutions.

FDA approve Medtronic‘s SCS device, Inceptiv

Medtronic plc, a global leader in healthcare technology, announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.

Post-Operative Pain Drugs Assessment

Understand the trends shaping and driving the Post-Operative Pain (POP) market and develop your strategies accordingly.

See a Sample

Newsletters in other sectors

Travel and Tourism

Las Vegas landmark the Mirage to close doors
20 May 2024

Explore our market-leading Intelligence Centers

Still looking?

Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries

Explorer

Access more premium companies when you subscribe to Explorer